Not Tagged
Not Tagged
['solid tumor', 'melanoma', 'award', 'pioneer']
presenting our merit award-winning and pioneering the re-raffle study under the amazing mentorship of dr. which found 50% of patients retreated with raf inhibitors had survival and response in various solid tumors beyond melanoma at #asco2023 
Early Phase Clinical Trials Fellow at M.D. Anderson Cancer | Former UTMB Chief Fellow | RT Alumni CMC Vellore